Literature DB >> 21953419

Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration.

Meggan Mackay1, Mathew P Bussa, Cynthia Aranow, Aziz M Uluğ, Bruce T Volpe, Patricio T Huerta, Miklos Argyelan, Arthur Mandel, Joy Hirsch, Betty Diamond, David Eidelberg.   

Abstract

The mediators of tissue damage in systemic lupus erythematosus (SLE) such as antibodies, cytokines and activated immune cells have direct access to most organs in the body but must penetrate the blood-brain barrier (BBB) to gain access to brain tissue. We hypothesized that compromise of the BBB occurs episodically such that the brain will acquire tissue damage slowly and not at the same rate as other organs. On the basis of these assumptions, we wished to determine if duration of disease correlated with brain injury, as measured with functional magnetic resonance imaging (fMRI), and if this was independent of degree of tissue damage in other organs. We investigated differences in brain activation patterns using fMRI in 13 SLE patients stratified by disease duration of ≤2 years (short-term [ST]) or ≥10 years (long-term [LT]). Two fMRI paradigms were selected to measure working memory and emotional response (fearful faces task). Performance in the working memory task was significantly better in the ST group for one and two shape recall; however, both groups did poorly with three shape recall. Imaging studies demonstrated significantly increased cortical activation in the ST group in regions associated with cognition during the two shape retention phase of the working memory task (P < 0.001) and increased amygdala (P < 0.05) and superior parietal (P < 0.01) activation in response to the fearful faces paradigm. In conclusion, analysis of activation patterns stratified by performance accuracy, differences in co-morbid disease, corticosteroid doses or disease activity suggests that these observed differences are attributable to SLE effects on the central nervous system exclusive of vascular disease or other confounding influences. Our hypothesis is further supported by the lack of correlation between regional brain abnormalities on fMRI and the Systemic Lupus International Collaborating Clinics (SLICC) damage index.

Entities:  

Mesh:

Year:  2011        PMID: 21953419      PMCID: PMC3321819          DOI: 10.2119/molmed.2011.00185

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  59 in total

1.  Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.

Authors:  Thomas W Faust; Eric H Chang; Czeslawa Kowal; RoseAnn Berlin; Irina G Gazaryan; Eva Bertini; Jie Zhang; Jorge Sanchez-Guerrero; Hilda E Fragoso-Loyo; Bruce T Volpe; Betty Diamond; Patricio T Huerta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Task-independent and task-specific age effects on brain activity during working memory, visual attention and episodic retrieval.

Authors:  Roberto Cabeza; Sander M Daselaar; Florin Dolcos; Steven E Prince; Matthew Budde; Lars Nyberg
Journal:  Cereb Cortex       Date:  2004-04       Impact factor: 5.357

Review 3.  The blood-brain barrier and immune function and dysfunction.

Authors:  William A Banks; Michelle A Erickson
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

Review 4.  The acquisition of skilled motor performance: fast and slow experience-driven changes in primary motor cortex.

Authors:  A Karni; G Meyer; C Rey-Hipolito; P Jezzard; M M Adams; R Turner; L G Ungerleider
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease.

Authors:  E Kozora; L L Thompson; S G West; B L Kotzin
Journal:  Arthritis Rheum       Date:  1996-12

6.  High-speed scanning in human memory.

Authors:  S Sternberg
Journal:  Science       Date:  1966-08-05       Impact factor: 47.728

7.  Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Mathias Ndhlovu; Beate E Preuss; Jörn Dengjel; Stefan Stevanovic; Stefan M Weiner; Reinhild Klein
Journal:  Brain Behav Immun       Date:  2010-09-25       Impact factor: 7.217

8.  Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution.

Authors:  Brian T Hawkins; Thomas J Abbruscato; Richard D Egleton; Rachel C Brown; Jason D Huber; Christopher R Campos; Thomas P Davis
Journal:  Brain Res       Date:  2004-11-19       Impact factor: 3.252

Review 9.  The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.

Authors:  Paul M Carvey; Bill Hendey; Angela J Monahan
Journal:  J Neurochem       Date:  2009-07-31       Impact factor: 5.372

10.  Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.

Authors:  E Sherwood Brown; Dixie J Woolston; Alan Frol; Leonardo Bobadilla; David A Khan; Margaret Hanczyc; A John Rush; James Fleckenstein; Evelyn Babcock; C Munro Cullum
Journal:  Biol Psychiatry       Date:  2004-03-01       Impact factor: 13.382

View more
  15 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Connective tissue diseases: Functional MRI in SLE-the current state.

Authors:  Anselm Mak; Sen Hee Tay
Journal:  Nat Rev Rheumatol       Date:  2015-10-20       Impact factor: 20.543

Review 3.  Integrative neuroscience approach to neuropsychiatric lupus.

Authors:  Patricio T Huerta; Elizabeth L Gibson; Carson Rey; Tomás S Huerta
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 4.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

5.  Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus.

Authors:  Meggan Mackay; Chris C Tang; Bruce T Volpe; Cynthia Aranow; Paul J Mattis; Ricki A Korff; Betty Diamond; David Eidelberg
Journal:  Lupus Sci Med       Date:  2015-03-28

6.  Alterations of white matter structural networks in patients with non-neuropsychiatric systemic lupus erythematosus identified by probabilistic tractography and connectivity-based analyses.

Authors:  Man Xu; Xiangliang Tan; Xinyuan Zhang; Yihao Guo; Yingjie Mei; Qianjin Feng; Yikai Xu; Yanqiu Feng
Journal:  Neuroimage Clin       Date:  2016-12-20       Impact factor: 4.881

7.  Impaired decision-making and functional neuronal network activity in systemic lupus erythematosus.

Authors:  Bei-Bei Wu; Ye Ma; Lei Xie; Jin-Zhuang Huang; Zong-Bo Sun; Zhi-Duo Hou; Rui-Wei Guo; Zhi-Rong Lin; Shou-Xing Duan; Shan-Shan Zhao; Dan-Miao Sun; Chun-Min Zhu; Shu-Hua Ma
Journal:  J Magn Reson Imaging       Date:  2018-03-14       Impact factor: 4.813

8.  Functional neuronal network activity differs with cognitive dysfunction in childhood-onset systemic lupus erythematosus.

Authors:  Mark W DiFrancesco; Darren R Gitelman; Marisa S Klein-Gitelman; Anna Carmela P Sagcal-Gironella; Frank Zelko; Dean Beebe; Todd Parrish; Jessica Hummel; Jun Ying; Hermine I Brunner
Journal:  Arthritis Res Ther       Date:  2013-03-07       Impact factor: 5.156

9.  Regional brain metabolism in a murine systemic lupus erythematosus model.

Authors:  An Vo; Bruce T Volpe; Chris C Tang; Wynne K Schiffer; Czeslawa Kowal; Patricio T Huerta; Aziz M Uluğ; Stephen L Dewey; David Eidelberg; Betty Diamond
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-14       Impact factor: 6.200

10.  Altered white matter microstructure in lupus patients: a diffusion tensor imaging study.

Authors:  Jessika Nystedt; Markus Nilsson; Andreas Jönsen; Petra Nilsson; Anders Bengtsson; Åsa Lilja; Jimmy Lätt; Peter Mannfolk; Pia C Sundgren
Journal:  Arthritis Res Ther       Date:  2018-02-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.